Abstract
Background:National projections about the increase in the elderly population over 60 years bring with it an increase in the number of people affected by Parkinson's Disease (PD), making it an important public health problem. Therefore, the establishment of effective strategies for intervention in people with PD needs to be more clearly investigated.Objective: The study aimed to report the effectiveness of exercise on functional capacity and neurobiological mechanisms in people with PD.Methods:This study is a critical review of the literature.Results:The progressive death of dopaminergic neurons in the substantia nigra is described as one of the main physiological mechanisms manifested before PD, directly interfering with motor behavior. However, PD is not only related to motor symptoms, but also to cognitive, autonomic, and mood impairments. Such effects may be attenuated by pharmacological influence, but also evidence suggests that the implementation of regular physical exercise programs may exhibit potential benefits over PD. The synthesis and expression of monoaminergic neurotransmitters can act positively on motor disorders, as well as directly or indirectly influence the neuronal plasticity of the brain, restoring neuronal pathways previously affected.Conclusion:Physical exercise contributes effectively to the treatment of PD, and can play a preventive and maintenance role of physical fitness and mental health.
Highlights
Parkinson's Disease (PD) is the second most common prevalent neurodegenerative disease, only behind Alzheimer's disease [1, 2]
The progressive death of dopaminergic neurons in the substantia nigra is described as one of the main physiological mechanisms manifested before PD, directly interfering with motor behavior
PD is related to motor symptoms, and to cognitive, autonomic, and mood impairments. Such effects may be attenuated by pharmacological influence, and evidence suggests that the implementation of regular physical exercise programs may exhibit potential benefits over PD
Summary
Parkinson's Disease (PD) is the second most common prevalent neurodegenerative disease, only behind Alzheimer's disease [1, 2]. Described in 1817 by a physician named James Parkinson [3], it is one of the chronic diseases associated with aging, as well as risk factors such as exposure to drugs, head trauma, pesticides (rotenone, paraquat, maneb) and drugs (cocaine, heroin) [4]. According to the World Health Organization, the global incidence rate of PD is estimated to be around 4.5 to 19 per 100,000 inhabitants, affecting both genders and races [7]. Considering the increase in the life expectancy of the world population, and of the aging, it is possible to estimate an increase in the number of people affected by PD, making it an important global public health problem. National projections about the increase in the elderly population over 60 years bring with it an increase in the number of people affected by Parkinson's Disease (PD), making it an important public health problem. The establishment of effective strategies for intervention in people with PD needs to be more clearly investigated
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical Practice & Epidemiology in Mental Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
